Citation Impact
Citing Papers
Identification of a physiological E2 module for the human anaphase-promoting complex
2009
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Flavivirus Replication Complex Assembly Revealed by DNAJC14 Functional Mapping
2012 StandoutNobel
Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome
2010
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors
2002
Bioluminescent imaging of Cdk2 inhibition in vivo
2004 StandoutNobel
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
2011
Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation
2006
Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death
2005
Toward a Personalized Medicine Approach to the Management of Inflammatory Bowel Disease
2014
Modular and tunable biological feedback control using a de novo protein switch
2019 StandoutNatureNobel
Autophagy and the Integrated Stress Response
2010 Standout
Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice
2006
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
2010 Standout
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
Function and regulation of cullin–RING ubiquitin ligases
2005 Standout
Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner
2011
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression
2008 Standout
VHL and p53: Tumor Suppressors Team Up to Prevent Cancer
2006 StandoutNobel
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity
2012 StandoutNobel
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Ubiquitin ligases: cell-cycle control and cancer
2006
Sequential E2s Drive Polyubiquitin Chain Assembly on APC Targets
2007
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
Crohn's disease
2016 Standout
The P53 pathway: what questions remain to be explored?
2006
Tracking and Elucidating Alphavirus-Host Protein Interactions
2006 StandoutNobel
Molecular Mechanisms of Long Noncoding RNAs
2011 Standout
Graft-versus-host disease
2009 Standout
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
p53 in health and disease
2007 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Targeted Proteomic Study of the Cyclin-Cdk Module
2004
The RAD6 DNA Damage Tolerance Pathway Operates Uncoupled from the Replication Fork and Is Functional Beyond S Phase
2010
The anaphase-promoting complex: it's not just for mitosis any more
2002
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
Fluorescent Proteins as Proteomic Probes
2005
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
2008
Molecular mechanisms of necroptosis: an ordered cellular explosion
2010 Standout
A LOV2 Domain-Based Optogenetic Tool to Control Protein Degradation and Cellular Function
2013
Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex
2004 StandoutNatureNobel
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
Phosphorylation of Chs2p regulates interaction with COPII
2013 StandoutNobel
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
Immune modulation by mesenchymal stem cells
2006
The PI3K Pathway in Human Disease
2017 Standout
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Targeting polo-like kinase 1 for cancer therapy
2006
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program
2008
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects
2004
Hypoxia and cell cycle regulation of the von Hippel–Lindau tumor suppressor
2010
Matrix Elasticity Directs Stem Cell Lineage Specification
2006 Standout
The spindle-assembly checkpoint in space and time
2007 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21
2015 StandoutNobel
Resolving the composition of protein complexes using a MALDI LTQ orbitrap
2009
PTEN
2014
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
2001
Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies
2008
A contractile and counterbalancing adhesion system controls the 3D shape of crawling cells
2014 StandoutNobel
Acute Myeloid Leukemia
2015 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Host Factors Associated with the Sindbis Virus RNA-Dependent RNA Polymerase: Role for G3BP1 and G3BP2 in Virus Replication
2010 StandoutNobel
New Ways to Use DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndrome
2011
Dissecting Temporal and Spatial Control of Cytokinesis with a Myosin II Inhibitor
2003 Science
Tissue Cells Feel and Respond to the Stiffness of Their Substrate
2005 StandoutScience
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation
2004
Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome
2004 StandoutNobel
RING Domain E3 Ubiquitin Ligases
2009 Standout
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
2010
The Ubiquitin Code
2012 Standout
Multiple Myeloma
2011 Standout
Dependence of Chs2 ER export on dephosphorylation by cytoplasmic Cdc14 ensures that septum formation follows mitosis
2011
Chemical Glycoproteomics
2016 StandoutNobel
Works of Ralph Wäsch being referenced
Reduced Intensity Conditioning Compared to Standard Conditioning Preserves the In Vitro Growth Capacity of Bone Marrow Stroma, Which Remains of Host Origin
2005
Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cells
2005
The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression
2009
State of the art therapy in multiple myeloma and future perspectives
2006
Strong inducible knockdown of APC/CCdc20does not cause mitotic arrest in human somatic cells
2009
Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin
2000
APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit
2002 Nature
Non-intensive treatment with low-dose 5-aza-2′-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients
2009
The ubiquitin ligase APCCdh1 is required to maintain genome integrity in primary human cells
2007
Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation
2000
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting
2009
Posaconazole Therapeutic Drug Monitoring in the Real‐life Setting: A Single‐Center Experience and Review of the Literature
2013
Genetic and Biochemical Evaluation of the Importance of Cdc6 in Regulating Mitotic Exit
2003
Prognostic Factor and Quality of Life Analysis in 160 Patients Aged ≥60 Years with Hematologic Neoplasias Treated with Allogeneic Hematopoietic Cell Transplantation
2010
Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer
2014